X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9068) 9068
Book Review (2391) 2391
Publication (1102) 1102
Book Chapter (98) 98
Book / eBook (62) 62
Conference Proceeding (6) 6
Data Set (3) 3
Dissertation (3) 3
Reference (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7855) 7855
animals (5561) 5561
humans (4140) 4140
male (3746) 3746
mice (2983) 2983
liver (2587) 2587
rats (1965) 1965
liver - metabolism (1823) 1823
oxidative stress (1722) 1722
female (1691) 1691
obesity (1672) 1672
liver - drug effects (1632) 1632
liver - pathology (1555) 1555
inflammation (1472) 1472
insulin resistance (1356) 1356
rodents (1336) 1336
liver diseases (1310) 1310
metabolism (1287) 1287
pharmacology & pharmacy (1261) 1261
insulin-resistance (1251) 1251
biochemistry & molecular biology (1243) 1243
mice, inbred c57bl (1198) 1198
diet-induced obesity (1189) 1189
physiological aspects (1071) 1071
endocrinology & metabolism (1067) 1067
gastroenterology & hepatology (1065) 1065
fatty liver (1003) 1003
disease models, animal (953) 953
toxicology (933) 933
analysis (882) 882
diet (853) 853
article (849) 849
lipids (842) 842
research (841) 841
hepatic steatosis (830) 830
cell biology (802) 802
gene expression (792) 792
health aspects (790) 790
risk factors (781) 781
disease (779) 779
hepatotoxicity (763) 763
steatosis (756) 756
fatty liver - chemically induced (755) 755
induced insulin-resistance (746) 746
metabolic syndrome (741) 741
fatty acids (739) 739
diabetes (713) 713
expression (713) 713
nutrition & dietetics (709) 709
glucose (705) 705
apoptosis (703) 703
proteins (701) 701
middle aged (686) 686
rats, wistar (679) 679
insulin (678) 678
adult (658) 658
adipose-tissue (646) 646
obesity - metabolism (637) 637
gene-expression (621) 621
lipid metabolism (619) 619
rats, sprague-dawley (617) 617
chemical and drug induced liver injury - pathology (595) 595
chemical and drug induced liver injury - etiology (592) 592
fatty liver - metabolism (592) 592
abridged index medicus (589) 589
nonalcoholic steatohepatitis (586) 586
fibrosis (573) 573
physiology (572) 572
medicine (568) 568
research article (555) 555
antioxidants (552) 552
toxicity (547) 547
signal transduction (534) 534
oxidative stress - drug effects (530) 530
medicine, research & experimental (527) 527
fatty liver-disease (523) 523
mice, knockout (522) 522
fatty liver - pathology (517) 517
activation (516) 516
enzymes (516) 516
multidisciplinary sciences (489) 489
body weight (476) 476
review (463) 463
type 2 diabetes (442) 442
triglycerides (436) 436
chemical and drug induced liver injury - metabolism (433) 433
care and treatment (430) 430
homeostasis (416) 416
alcohol (414) 414
ethanol (413) 413
nf-kappa-b (410) 410
cells (409) 409
cholesterol (402) 402
hepatitis (401) 401
hepatocytes - metabolism (401) 401
medicine & public health (395) 395
cancer (394) 394
induced liver-injury (390) 390
gastroenterology and hepatology (384) 384
carbon tetrachloride (383) 383
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (41) 41
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
UofT at Scarborough - Stacks (3) 3
Online Resources - Online (2) 2
Pharmacy (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9118) 9118
French (23) 23
Spanish (14) 14
German (12) 12
Japanese (10) 10
Italian (7) 7
Chinese (5) 5
Polish (4) 4
Russian (3) 3
Dutch (2) 2
Romanian (2) 2
Czech (1) 1
Danish (1) 1
Korean (1) 1
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BBA - Molecular Basis of Disease, ISSN 0925-4439, 06/2018, Volume 1864, Issue 6, pp. 2067 - 2077
As a widely used anti-gout drug, benzbromarone has been found to induce hepatic toxicity in patients during clinical treatment. Previous studies have reported... 
Obesity | Benzbromarone | Hepatic steatosis | Hepatotoxicity | OXIDATIVE STRESS | LIPID-PEROXIDATION | RAT HEPATOCYTES | FATTY LIVER-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOPLASMIC-RETICULUM STRESS | IN-VITRO | BIOPHYSICS | TRIGLYCERIDE SYNTHESIS | UP-REGULATION | URIC-ACID | ADIPOSE-TISSUE | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Apoptosis - drug effects | Humans | Middle Aged | Diet, High-Fat - adverse effects | Non-alcoholic Fatty Liver Disease - etiology | Hepatocytes - pathology | Male | Hepatocytes - metabolism | Obesity - blood | Obesity - genetics | Young Adult | Fatty Acids, Nonesterified - metabolism | Liver - drug effects | Adult | Female | Benzbromarone - pharmacology | Chemical and Drug Induced Liver Injury - blood | Chemical and Drug Induced Liver Injury - pathology | Hepatocytes - drug effects | Disease Models, Animal | Obesity - complications | Liver - metabolism | Mice, Inbred C57BL | Mice, Transgenic | Non-alcoholic Fatty Liver Disease - metabolism | Hep G2 Cells | Hyperuricemia - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Obesity - metabolism | Hyperuricemia - blood | Animals | Benzbromarone - therapeutic use | Uricosuric Agents - pharmacology | Lipid Metabolism - drug effects | Transaminases - blood | Aged | Liver - cytology | Mice | Oxidative Stress - drug effects | Uricosuric Agents - therapeutic use | Medical research | Liver diseases | Liver | Physiological aspects | Medicine, Experimental | Triglycerides | Fatty acids | Index Medicus
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 08/2013, Volume 305, Issue 3, pp. 214 - 224
Journal Article
Journal Article
The Journal of Physiology, ISSN 0022-3751, 09/2019, Volume 597, Issue 17, pp. 4565 - 4580
Journal Article
Current Opinion in Clinical Nutrition and Metabolic Care, ISSN 1363-1950, 07/2016, Volume 19, Issue 5, pp. 360 - 365
PURPOSE OF REVIEWThe high worldwide prevalence of nonalcoholic fatty liver disease (NAFLD) makes it a major public health issue. Amino acids offer a promising... 
adipose tissue | nonalcoholic fatty liver disease | amino acid | gut | muscle | ACID RELEASE | HOMEOSTASIS | LIPID-METABOLISM | VISCERAL ADIPOSE-TISSUE | FATTY LIVER-DISEASE | RATS | DIET-INDUCED OBESITY | SUPPLEMENTATION | INSULIN | NUTRITION & DIETETICS | AMINO-ACIDS | ENDOCRINOLOGY & METABOLISM
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, pp. e0151511 - e0151511
Type 2 diabetes mellitus (T2DM) is associated with a high incidence of non-alcoholic fatty liver disease (NAFLD) related to obesity and insulin resistance.... 
ADIPOCYTE DEATH | HYPERGLYCEMIA | DAPAGLIFLOZIN | ELEMENT-BINDING PROTEIN-1 | INSULIN-RESISTANCE | GLUCOSE | MULTIDISCIPLINARY SCIENCES | DISEASE | DOUBLE-BLIND | COTRANSPORTER 2 INHIBITION | ADIPOSE-TISSUE | Epididymis - metabolism | Thiophenes - therapeutic use | Liver - pathology | Humans | Body Weight - drug effects | Diet, High-Fat - adverse effects | Non-alcoholic Fatty Liver Disease - etiology | Male | Hyperphagia - chemically induced | Adipose Tissue - metabolism | Liver - drug effects | Adult | Glucosides - therapeutic use | Drug Evaluation, Preclinical | Epididymis - drug effects | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Glucosides - pharmacology | Obesity - complications | Liver - metabolism | Mice, Inbred C57BL | Insulin Resistance | Thiophenes - pharmacology | Sodium-Glucose Transporter 2 Inhibitors | Energy Intake - drug effects | Hypoglycemic Agents - pharmacology | Non-alcoholic Fatty Liver Disease - drug therapy | Organ Size - drug effects | Animals | Weight Loss | Non-alcoholic Fatty Liver Disease - prevention & control | Glucose - metabolism | Mice, Obese | Mice | Lipids - analysis | Diabetes Mellitus, Type 2 - drug therapy | Leptin - deficiency | Adipose Tissue - drug effects | Type 2 diabetes | Complications and side effects | Fatty liver | Hypoglycemic agents | Dosage and administration | Drug therapy | Risk factors | Drugs | Adipose tissue | Body fat | Liver | Body weight | Homeostasis | Lipids | Adipocytes | Glucose | Proximal tubules | Accumulation | High fat diet | Liver cancer | Hyperglycemia | Energy | Rodents | Hyperphagia | Energy intake | Obesity | Excretion | Liver diseases | Kidneys | Research & development--R&D | Diabetes mellitus | Tubules | Reabsorption | Pharmacology | Metabolism | Insulin | Patients | Steatosis | Energy balance | Inhibitors | Sodium | Leptin | Weight reduction | Insulin resistance | Diabetes | Laboratory animals | Endocrinology | Kidney transplantation | Index Medicus | Research & development | R&D
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0119784 - e0119784
High-fat diet (HFD) has been applied to a variety of inbred mouse strains to induce obesity and obesity related metabolic complications. In this study, we... 
PROTECTS MICE | HYDRODYNAMIC DELIVERY | C57BL/6J MICE | INSULIN-RESISTANCE | GLUCOSE-INTOLERANCE | MULTIDISCIPLINARY SCIENCES | TISSUE | LIVER | MOUSE | WEIGHT-GAIN | INDUCED OBESITY | Tumor Necrosis Factor-alpha - metabolism | Adipose Tissue, White - pathology | Inflammation - pathology | Fatty Liver - blood | Fatty Liver - pathology | Diet, High-Fat - adverse effects | Weight Gain - physiology | Adipocytes - physiology | Obesity - blood | Adipose Tissue, Brown - pathology | Inflammation - blood | Obesity - pathology | Hyperinsulinism - pathology | Animals | Insulin Resistance - physiology | Triglycerides - blood | Adiposity - physiology | Chemokine CCL2 - metabolism | Mice | Hyperinsulinism - blood | Glucose Intolerance - physiopathology | Adipose tissues | Obesity | Cytokines | Diet | Liver | Body weight | Insulin resistance | Triglycerides | Inflammation | Glucose | Comparative analysis | Dextrose | Hyperinsulinemia | Adipose tissue | Body fat | Disorders | Adipocytes | High fat diet | Human populations | Fatty liver | Rodents | Inbreeding | Adipose tissue (brown) | Pancreas | Deposition | Complications | CD36 antigen | Tumor necrosis factor-α | Gene expression | Insulin | Body weight gain | Steatosis | Glucose tolerance | Intolerance | Pharmacy | Peroxisome proliferator-activated receptors | Islets of Langerhans | Chemokines | Monocyte chemoattractant protein 1 | Metabolic disorders | Hypertrophy | Pharmaceuticals | Index Medicus
Journal Article